Market Tracker

09/29 5:20pm ET
Customize

Abbvie Inc (NYSE:ABBV)

149.10
Delayed Data
As of Sep 29
 -3.15 / -2.07%
Today’s Change
130.96
Today|||52-Week Range
168.11
-7.74%
Year-to-Date
3 Magnificent Dividend Stocks to Buy in October
6:55am / MotleyFool.com - Paid Partner Content
AbbVie's (ABBV) Epcoritamab Gets Approval in Europe for DLBCL
Sep 26 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
Sep 29 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
Sep 25 / Zacks.com - Paid Partner Content
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Sep 29 / Zacks.com - Paid Partner Content
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Sep 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions
Sep 29 / Zacks.com - Paid Partner Content
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
Sep 21 / MotleyFool.com - Paid Partner Content
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
Sep 29 / Zacks.com - Paid Partner Content
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Sep 20 / Zacks.com - Paid Partner Content
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
Sep 29 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
Sep 18 / Zacks.com - Paid Partner Content
Top Analyst Reports for Oracle, AbbVie & Lowe's
Sep 28 / Zacks.com - Paid Partner Content
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Sep 18 / Zacks.com - Paid Partner Content
Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
Sep 28 / Zacks.com - Paid Partner Content